Search

Rasem Mourad

Examiner (ID: 7274, Phone: (571)270-7770 , Office: P/2836 )

Most Active Art Unit
2836
Art Unit(s)
2836
Total Applications
617
Issued Applications
444
Pending Applications
46
Abandoned Applications
142

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5284906 [patent_doc_number] => 20090098581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Tyrosine phosphorylation sites' [patent_app_type] => utility [patent_app_number] => 12/148547 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 36484 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098581.pdf [firstpage_image] =>[orig_patent_app_number] => 12148547 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/148547
Tyrosine phosphorylation sites Apr 17, 2008 Issued
Array ( [id] => 5336751 [patent_doc_number] => 20090053215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD63' [patent_app_type] => utility [patent_app_number] => 12/102983 [patent_app_country] => US [patent_app_date] => 2008-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19244 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053215.pdf [firstpage_image] =>[orig_patent_app_number] => 12102983 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/102983
Cytotoxicity mediation of cells evidencing surface expression of CD63 Apr 14, 2008 Abandoned
Array ( [id] => 4886303 [patent_doc_number] => 20080260635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of MCSP' [patent_app_type] => utility [patent_app_number] => 12/102953 [patent_app_country] => US [patent_app_date] => 2008-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15736 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260635.pdf [firstpage_image] =>[orig_patent_app_number] => 12102953 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/102953
Cytotoxicity mediation of cells evidencing surface expression of MCSP Apr 14, 2008 Abandoned
Array ( [id] => 5409541 [patent_doc_number] => 20090123439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'DIAGNOSTIC AND PROGNOSIS METHODS FOR CANCER STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/102558 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 46261 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123439.pdf [firstpage_image] =>[orig_patent_app_number] => 12102558 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/102558
DIAGNOSTIC AND PROGNOSIS METHODS FOR CANCER STEM CELLS Apr 13, 2008 Abandoned
Array ( [id] => 4675542 [patent_doc_number] => 20080213171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 12/102662 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5033 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213171.pdf [firstpage_image] =>[orig_patent_app_number] => 12102662 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/102662
Cancerous disease modifying antibodies Apr 13, 2008 Abandoned
Array ( [id] => 6453282 [patent_doc_number] => 20100105571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Protein Signature/Markers for the Detection of Adenocarcinoma' [patent_app_type] => utility [patent_app_number] => 12/593448 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10253 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105571.pdf [firstpage_image] =>[orig_patent_app_number] => 12593448 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/593448
Protein Signature/Markers for the Detection of Adenocarcinoma Mar 24, 2008 Abandoned
Array ( [id] => 6313801 [patent_doc_number] => 20100111874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHOD OF CANCER DETECTION AND TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/532375 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7876 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111874.pdf [firstpage_image] =>[orig_patent_app_number] => 12532375 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/532375
METHOD OF CANCER DETECTION AND TREATMENT Mar 16, 2008 Abandoned
Array ( [id] => 5508452 [patent_doc_number] => 20090081659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Reagents for the detection of protein phosphorylation in carcinoma signaling pathways' [patent_app_type] => utility [patent_app_number] => 12/075065 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 33369 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081659.pdf [firstpage_image] =>[orig_patent_app_number] => 12075065 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/075065
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways Mar 6, 2008 Abandoned
Array ( [id] => 6631870 [patent_doc_number] => 20100173322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways' [patent_app_type] => utility [patent_app_number] => 12/074876 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20537 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173322.pdf [firstpage_image] =>[orig_patent_app_number] => 12074876 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/074876
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways Mar 5, 2008 Abandoned
Array ( [id] => 6441715 [patent_doc_number] => 20100104586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Treatment of Carcinomas with a Combination of EGF-Pathway and Telomerase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/530014 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11454 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104586.pdf [firstpage_image] =>[orig_patent_app_number] => 12530014 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/530014
Treatment of carcinomas with a combination of EGF-pathway and telomerase inhibitors Mar 5, 2008 Issued
Array ( [id] => 4887486 [patent_doc_number] => 20080261818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Methods of Identifying Pancreatic Cancer Cells' [patent_app_type] => utility [patent_app_number] => 12/041350 [patent_app_country] => US [patent_app_date] => 2008-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10006 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261818.pdf [firstpage_image] =>[orig_patent_app_number] => 12041350 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/041350
Methods of identifying pancreatic cancer cells Mar 2, 2008 Issued
Array ( [id] => 4698852 [patent_doc_number] => 20080221036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 12/071757 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6504 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221036.pdf [firstpage_image] =>[orig_patent_app_number] => 12071757 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/071757
Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions Feb 25, 2008 Abandoned
Array ( [id] => 4823023 [patent_doc_number] => 20080227708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Methods Of Attenuating Prostate Tumor Growth By Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3)' [patent_app_type] => utility [patent_app_number] => 12/036822 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5151 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227708.pdf [firstpage_image] =>[orig_patent_app_number] => 12036822 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/036822
Methods Of Attenuating Prostate Tumor Growth By Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Feb 24, 2008 Abandoned
Array ( [id] => 4872738 [patent_doc_number] => 20080199472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells' [patent_app_type] => utility [patent_app_number] => 12/070239 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4655 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199472.pdf [firstpage_image] =>[orig_patent_app_number] => 12070239 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/070239
Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells Feb 13, 2008 Abandoned
Array ( [id] => 6395496 [patent_doc_number] => 20100178299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 12/527181 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33966 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20100178299.pdf [firstpage_image] =>[orig_patent_app_number] => 12527181 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/527181
METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSES Feb 12, 2008 Abandoned
Array ( [id] => 4873653 [patent_doc_number] => 20080200387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'ANTI-ANGIOGENIC PROTEIN, COMPOSITION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/030847 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8168 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200387.pdf [firstpage_image] =>[orig_patent_app_number] => 12030847 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/030847
ANTI-ANGIOGENIC PROTEIN, COMPOSITION AND USE THEREOF Feb 12, 2008 Abandoned
Array ( [id] => 6322974 [patent_doc_number] => 20100113747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Coupling of Antibody Polypeptides at the C-Terminus' [patent_app_type] => utility [patent_app_number] => 12/528905 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15929 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113747.pdf [firstpage_image] =>[orig_patent_app_number] => 12528905 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/528905
Coupling of Antibody Polypeptides at the C-Terminus Feb 7, 2008 Abandoned
Array ( [id] => 4711682 [patent_doc_number] => 20080300208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Isociatrate dehydrogenase and uses therof' [patent_app_type] => utility [patent_app_number] => 12/069188 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17425 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300208.pdf [firstpage_image] =>[orig_patent_app_number] => 12069188 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/069188
Isociatrate dehydrogenase and uses therof Feb 6, 2008 Abandoned
Array ( [id] => 4859105 [patent_doc_number] => 20080267955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'FRIZZLED 9 AS TUMOR MARKER' [patent_app_type] => utility [patent_app_number] => 12/019608 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10179 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267955.pdf [firstpage_image] =>[orig_patent_app_number] => 12019608 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/019608
FRIZZLED 9 AS TUMOR MARKER Jan 23, 2008 Abandoned
Array ( [id] => 4726591 [patent_doc_number] => 20080206132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Cancerous Disease Modifying Antibodies' [patent_app_type] => utility [patent_app_number] => 12/017827 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17364 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206132.pdf [firstpage_image] =>[orig_patent_app_number] => 12017827 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/017827
Cancerous disease modifying antibodies Jan 21, 2008 Issued
Menu